Susannah Streeter and Philippe Wolgen, CEO of the CLINUVEL Group, discuss the Company’s culture, the impact of capital markets, the importance of building relationships, and more.
Part one of three focuses on the Company’s approach to navigating shifting markets and unexpected events, and the commercialisation of CLINUVEL’s lead product, including interactions with England’s National Institute for Health and Care Excellence (NICE) and a landmark decision in 2017.
Stay tuned for more.